COX inhibitors for airway inflammation

Bibliography

• Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 1997;17:3S-12
   Google Scholar
• Henderson WR Jr. Role of leukotrienes in asthma. Ann Allergy 1994;72:272-8
   PubMedGoogle Scholar
• O'Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997;111:27S-34
   PubMed Web of Science ®Google Scholar
• Rubin P, Mollison KW. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat 2007;83:188-97
   PubMed Web of Science ®Google Scholar
• Rolina S, Masereela B. DogneJ-M. Prostanoids as pharmacological targets in COPD and asthma. Eur J Pharmacol 2006;533:89-100
   PubMedGoogle Scholar
• Carey MA, Germolec DR, Langenbach R, Zeldin DC. Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 2003;69:157-62
   PubMed Web of Science ®Google Scholar
• Sousa AR, Pfister R, Christie PE, Enhanced expression of cyclo-oxygenase 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin sensitive asthma. Thorax 1997;52:940-5
   PubMed Web of Science ®Google Scholar
• Pang L, Pitt A, Petkova D, Knox AJ. The COX-1/COX-2 balance in asthma. Clin Exp Allergy 1998;28:1050-8
   PubMedGoogle Scholar
• Montuschi P, Peters-Golden ML. Leukotriene modifiers for asthma treatment. Clin Exp Allergy 2010;40:1732-41
   PubMed Web of Science ®Google Scholar
• Montuschi P, Macagno F, Parente P, Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 2005;60:827-33
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999;128:1121-32
   PubMed Web of Science ®Google Scholar
• Ramalho TC, Rocha MVJ, da Cunha EFF, Freitas MP. The search for new COX-2 inhibitors: a review of 2002 – 2008 patents. Expert Opin Ther Patents 2009;19:1-36
   PubMedGoogle Scholar
• Schuligoi R, Sedej M, Waldhoer M, Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. J Leukoc Biol 2009;85:136-45
   PubMedGoogle Scholar
• Graf BA, Nazarenko DA, Borrello MA, Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals. Eur J Immunol 1999;29:3793-803
   PubMedGoogle Scholar
• Mitchell JA, Evans TW. Cyclooxygenase-2 as a therapeutic target. Inflamm Res 1998;47:S88-92
   Google Scholar
• Abramovitz M, Metters KM. Prostanoid receptors. Ann Rep Med Chem 1998;33:223-31
   Google Scholar
• Hardy CC, Bradding P, Robinson C, Holgate ST. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 1988;64:1567-74
   PubMed Web of Science ®Google Scholar
• Mathe AA, Hedqvist P. Effect of prostaglandins F2alpha and E2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis 1975;111:313-20
   PubMed Web of Science ®Google Scholar
• Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984;311:209-13
   PubMed Web of Science ®Google Scholar
• Hamberg M, Samuelsson B. On the mechanism of the biosynthesis of prostaglandins E1 and F1alpha. J Biol Chem 1967;242:5336-43
   PubMed Web of Science ®Google Scholar
• Goodwin DC, Gunther MH, Hsi LH, Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover. Detection of the radical derivative of tyrosine 385. J Biol Chem 1998;273:8903-9
   PubMed Web of Science ®Google Scholar
• Malkowski MG, Ginell SL, Smith WL, Garavito RM. The productive conformation of arachidonic acid bound to prostaglandin synthase. Science 2000;289:1933-7
   PubMed Web of Science ®Google Scholar
• Tsai AL, Palmer G, Xiao G, Structural characterization of arachidonyl radicals formed by prostaglandin H synthase-2 and prostaglandin H synthase-1 reconstituted with mangano protoporphyrin IX. J Biol Chem 1998;273:3888-94
   PubMedGoogle Scholar
• Dean AM, Dean FM. Carbocations in the synthesis of prostaglandins by the cyclooxygenase of PGH synthase? A radical departure!. Protein Sci 1999;8:1087-98
   PubMedGoogle Scholar
• Miyamoto T, Ogino M, Yamamoto S, Hayaishin O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 1976;259:2629-36
   Google Scholar
• DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988;85:1412-16
   PubMed Web of Science ®Google Scholar
• Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988;263:3550-3
   PubMed Web of Science ®Google Scholar
• Yokoyama C, Takai T, Tanabe T. Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence. FEBS Lett 1988;231:347-51
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86:1375-9
   PubMed Web of Science ®Google Scholar
• Xie WL, Chipman JG, Robertson DL, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6
   PubMed Web of Science ®Google Scholar
• Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 1992;267:7991-4
   PubMed Web of Science ®Google Scholar
• Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 2000;69:145-82
   PubMed Web of Science ®Google Scholar
• Smith WL, DeWitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 1996;62:167-215
   PubMed Web of Science ®Google Scholar
• Demoly P, Jaffuel D, Lequeux N, Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med 1997;155:670-5
   PubMed Web of Science ®Google Scholar
• Bonner JC, Rice AB, Ingram JL, Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 2002;161:459-70
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat Rev Biol 1971;231:232-5
   Google Scholar
• Fu JY, Masferrer JL, Seibert K, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human. J Biol Chem 1990;265:16737-40
   PubMed Web of Science ®Google Scholar
• Xie W, Chipman JG, Robertson DL, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6
   PubMed Web of Science ®Google Scholar
• Kujubu DA, Fletcher BS, Varnum BC, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72
   PubMed Web of Science ®Google Scholar
• O'Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4 kb mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Zweifel BS, Manning PT, Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994;91:3228-32
   PubMed Web of Science ®Google Scholar
• Simon LS, Lanza FL, Lipsky PE, Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase-2 inhibitor. Arthritis Rheum 1998;41:1591-602
   PubMed Web of Science ®Google Scholar
• Pang L, Knox AJ. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclooxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol 1997;121:579-87
   PubMed Web of Science ®Google Scholar
• Lazzeri N, Belvisi MG, Patel HJ, Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells: relevance to asthma therapy. Am J Respir Mol Cell Biol 2001;24:44-8
   PubMed Web of Science ®Google Scholar
• McKay S, Sharma HS. Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir Res 2002;3:11-23
   PubMedGoogle Scholar
• Montuschi P, Curro D, Ragazzoni E, Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro. Eur J Pharmacol 1999;365:59-64
   PubMed Web of Science ®Google Scholar
• Morham SG, Langenbach R, Loftin CD, Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995;83:473-82
   PubMed Web of Science ®Google Scholar
• Gavett SH, Madison SL, Chulada PC, Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest 1999;104:721-32
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Wohlford-Lenane C, Chulada P, Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2001;25:457-65
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Belvisi MG, Akarasereenont P, Induction of cyclooxygenase 2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994;113:1008-14
   PubMed Web of Science ®Google Scholar
• Vigano T, Habib A, Hernandez A, Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth muscle cells. Am J Respir Crit Care Med 1997;155:864-8
   PubMedGoogle Scholar
• Taha R, Olivenstein R, Utsumi T, Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:636-40
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kamio Y, Kasahara K, Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995;8:1499-505
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Fujimura M, Yamamoto H, COX-2 Inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. J Investig Allergol Clin Immunol 2009;19:370-4
   PubMedGoogle Scholar
• Hay DWP, Trophy TJ, Undem BJ. Cysteinyl-leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995;16:304-9
   PubMed Web of Science ®Google Scholar
• Griffin M, Weiss JW, Leitch AG, Effects of leukotriene D on the airways in asthma. N Engl J Med 1983;308:436-9
   PubMed Web of Science ®Google Scholar
• Laitinen LA, Laitinen A, Haahtela T, Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-90
   PubMed Web of Science ®Google Scholar
• Pavord ID, Tatterfield AE. Bronchoprotective role for endogenous prostaglandin E2. Lancet 1995;345:436-8
   PubMed Web of Science ®Google Scholar
• Curzen N, Rafferty P, Holgate ST. The effect of flurbiprofen, a cyclooxygenase inhibitor, and terfenadine, alone and in combination, on allergen-induced immediate bronchoconstriction. Thorax 1987;42:946-52
   PubMedGoogle Scholar
• Matsuoka T, Hirata M, Tanaka H, Prostaglandin D2 as a mediator of allergic asthma. Science 2000;287:2013-17
   PubMed Web of Science ®Google Scholar
• Hirai H, Tanaka K, Yoshie O, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-62
   PubMed Web of Science ®Google Scholar
• Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003;58:585-8
   PubMed Web of Science ®Google Scholar
• Montuschi P, Martello S, Felli M, Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children. Respir Res 2005;6:119
   PubMed Web of Science ®Google Scholar
• O'Sullivan S, Dahlen SE, Larsson K, Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine. Thorax 1998;53:1041-6
   PubMedGoogle Scholar
• Bochenek G, Nizankowska E, Gielicz A, Plasma 9alpha,11ß-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004;59:459-64
   PubMed Web of Science ®Google Scholar
• Monneret G, Gravel S, Diamond M, Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001;98:1942-8
   PubMed Web of Science ®Google Scholar
• Emery DL, Djokic TD, Graf PD, Nadel JA. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. J Appl Physiol 1989;67:959-62
   PubMed Web of Science ®Google Scholar
• Woodward DF, Hawley SB, Williams LS, Studies on the ocular pharmacology of prostaglandin D2. Invest Ophthalmol Vis Sci 1990;31:138-46
   PubMed Web of Science ®Google Scholar
• Oguma T, Asano K, Shiomi T, Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs. Am J Respir Crit Care Med 2002;165:382-3
   PubMed Web of Science ®Google Scholar
• Gervais FG, Cruz RP, Chateauneuf A, Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001;108:982-8
   PubMed Web of Science ®Google Scholar
• Yang C-M, Lee I-T, Lin C-C, Cigarette smoke extract induces COX-2 expression via a PKCalpha/c-Src/EGFR, PDGFR/PI3K/Akt/NF-kappaB pathway and p300 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2009;297:892-902
   Google Scholar
• Moodie FM, Marwick JA, Anderson CS, Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J 2004;18:1897-9
   PubMed Web of Science ®Google Scholar
• Van der TM, Rezayat D, Kauffman HF, Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009;297:L109-14
   Google Scholar
• Stavrides JC. Lung carcinogenesis: pivotal role of metals in tobacco smoke. Free Radic Biol Med 2006;41:1017-30
   PubMed Web of Science ®Google Scholar
• Park YS, Kim J, Misonou Y, Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler Thromb Vasc Biol 2007;27:1319-25
   PubMed Web of Science ®Google Scholar
• Moretto N, Facchinetti F, Southworth T, Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol 2009;296:L839-48
   Web of Science ®Google Scholar
• Martey CA, Baglole CJ, Gasiewicz TA, The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2005;289:L391-9
   PubMed Web of Science ®Google Scholar
• Hirst SJ, Martin JG, Bonacci JV, Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004;114:S2-17
   PubMedGoogle Scholar
• Howarth PH, Knox AJ, Amrani Y, Synthetic responses in airway smooth muscle. J Allergy Clin Immunol 2004;114:S32-50
   PubMedGoogle Scholar
• Ito K, Caramori G, Adcock IM. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 2007;321:1-8
   PubMed Web of Science ®Google Scholar
• Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003;4:313-19
   PubMed Web of Science ®Google Scholar
• Hsieh HL, Wu CB, Sun CC, Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. J Cell Physiol 2006;207:757-66
   PubMed Web of Science ®Google Scholar
• Jorgensen E, Stinson A, Shan L, Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer 2008;8:229
   PubMed Web of Science ®Google Scholar
• Xu K, Kitchen CM, Shu HK, Murphy TJ. Platelet-derived growth factor-induced stabilization of cyclooxygenase 2 mRNA in rat smooth muscle cells requires the c-Src family of protein-tyrosine kinases. J Biol Chem 2007a;282:32699-709
   PubMed Web of Science ®Google Scholar
• Xu K, Shu HK. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res 2007b;67:6121-9
   PubMed Web of Science ®Google Scholar
• Montuschi P, Sala A, Dahlen SE, Folco G. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Dis Today 2007;12:404-12
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Akarasereenont P, Thiemermann C, Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci 1993;90:11693-7
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13
   PubMed Web of Science ®Google Scholar
• Picado C, Castillo JA, Montserrat JM, Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989;2:127-9
   PubMedGoogle Scholar
• Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990;3:588-93
   PubMed Web of Science ®Google Scholar
• Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996;26:868-79
   PubMed Web of Science ®Google Scholar
• Sampson AP. The leukotrienes: mediators of chronic inflammation in asthma. Clin Exp Allergy 1996;26:995-1004
   PubMedGoogle Scholar
• Sanak M, Sampson AP. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma. Clin Exp Allergy 1999;29:306-13
   PubMed Web of Science ®Google Scholar
• Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991;144:957-8
   PubMedGoogle Scholar
• Sestini P, Armetti L, Gambaro G, Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153:572-5
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Sladek K, Dworski RJ, Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996;154:1608-14
   PubMedGoogle Scholar
• Bianco S, Robuschi M, Petrigni G, Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993;46:115-20
   PubMedGoogle Scholar
• Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998;53:1231-3
   PubMed Web of Science ®Google Scholar
• Dahlen B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin intolerance. The celecoxib in aspirin-intolerant asthma study group. N Engl J Med 2001;344:142
   PubMed Web of Science ®Google Scholar
• Martin-Garcia C, Hinojosa M, Berges P, Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 2002;121:1812-17
   PubMed Web of Science ®Google Scholar
• Rowlinson SW, Kiefer JR, Prusakiewicz JJ, A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem 2003;278:45763-9
   PubMed Web of Science ®Google Scholar
• Togias A, Naclerio RM, Proud D, Mediator release during nasal provocation: a model to investigate the pathophysiology of rhinitis. Am J Med 1985;79:26-33
   PubMedGoogle Scholar
• Van Adelsberg J, Philip G, LaForce CF, Randomised controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003;90:214-22
   PubMed Web of Science ®Google Scholar
• Ranatunge RR, Augustyniak M, Bandarage UK. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles. J Med Chem 2004;47:2180-93
   PubMed Web of Science ®Google Scholar
• Ranatunge RR, Garvey DS, Janero DR. Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles. Bioorg Med Chem 2004;12:1357-66
   PubMed Web of Science ®Google Scholar
• Ranatunge RR, Earl RA, Garvey DS. 3-(2-Methoxytetrahydrofuran-2-yl) pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 2004;14:6049-52
   PubMed Web of Science ®Google Scholar
• Available from: http://clinicaltrials.gov/ct2/show/NCT01002690
   Google Scholar